Subjective Cognitive Impairment Associated With Major Adverse CV Events in Patients With T2D
For individuals with type 2 diabetes, subjective cognitive impairment (SCI) is associated with cardiovascular events.
For individuals with type 2 diabetes, subjective cognitive impairment (SCI) is associated with cardiovascular events.
Researchers report findings from the ACCORD trial that evaluated the relationship of a blood pressure polygenic risk score with cardiovascular outcomes in individuals with type 2 diabetes.
A healthy diet may lower the risk for type 2 diabetes across all levels of genetic risk.
The American Heart Association has issued a scientific statement regarding the relationship between nonalcoholic fatty liver disease and cardiovascular risk.
Reducing glycated hemoglobin (HbA1c), systolic blood pressure (SBP), low-density lipoprotein cholesterol (LDL-C), and body mass index (BMI) can improve life expectancy (LE) among people with type 2 diabetes (T2D).
Investigators conducted a scoping review of randomized controlled trials that evaluated the impact of cognitive behavioral therapy on symptoms of depression and anxiety among patients with type 2 diabetes.
Researchers sought to evaluate the relationship between initiation of metformin and sulfonylurea therapy and clinical outcomes in patients with HF and diabetes.
A study was conducted to examine the relationship between multiple patient factors and use of glucagon-like peptide-1 receptor agonists in patients with ASCVD and T2D.
Investigators assessed whether depressive symptoms, eating disorders, and health-related quality of life were related to a diagnosis of type 2 diabetes in youth and young adults.
Investigators evaluated the effect of genomics-enhanced, questionnaire-based risk tools on polygenic risk scores for coronary heart disease and type 2 diabetes.